A Trial of Trans-radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy (RIVAL)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a multi-national, multi-centre, randomized study comparing the trans-radial PCI access strategy and the trans-femoral PCI access strategy in ACS patients with UA or NSTEMI or STEMI planned to be treated with an invasive strategy (PCI).
The hypothesis is that radial access site PCI will be associated with significantly less major bleeding and access site complications compared with a femoral approach, without increasing the risk of ischemic events. The overall benefit-risk profile will favor a trans-radial approach.
| Condition | Intervention | Phase |
|---|---|---|
|
Acute Coronary Syndrome Percutaneous Coronary Intervention |
Procedure: Percutaneous Coronary Intervention |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | An International Randomized Trial of Trans-radial Versus Trans-femoral PCI Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy. An Extension to the CURRENT (OASIS 7) Substudy (EFC5695): Effect of Type of Access for PCI (Radial or Femoral) on Bleeding Rate-Substudy. |
- First occurrence of the composite of death, MI, stroke or non CABG major bleeding (i.e. severe bleeding, other major bleeding) at 30 days. [ Time Frame: 30 days ] [ Designated as safety issue: No ]
- Non CABG major bleeding [ Time Frame: within 30 days following randomization ] [ Designated as safety issue: Yes ]
- Death, MI or stroke [ Time Frame: within 30 days following randomization ] [ Designated as safety issue: No ]
| Enrollment: | 7021 |
| Study Start Date: | June 2006 |
| Study Completion Date: | March 2011 |
| Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Trans-femoral access
Femoral artery PCI access site
|
Procedure: Percutaneous Coronary Intervention |
|
Active Comparator: Trans-radial access
Radial artery PCI access site
|
Procedure: Percutaneous Coronary Intervention |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA
1.1 UA/NSTEMI patients
Ischemic symptoms suspected to represent a non-ST segment elevation ACS (unstable angina [UA] or non-ST segment elevation myocardial infarction NSTEMI) defined as:
Clinical history consistent with new onset, or a worsening pattern, of characteristic ischemic chest pain occurring at rest or with minimal exercise (lasting longer than 10 minutes) and planned to be managed with an invasive strategy
AND at least one of the following:
Electrocardiogram (ECG) changes compatible with new ischemia [ST depression of at least 1mm or transient ST elevation or ST elevation of less than or equal to 1 mm or T wave inversion greater than 2 mm in at least 2 contiguous leads].
or
Patients > 60 years of age with normal ECG are eligible provided there is a high degree of certainty that presenting symptoms are due to myocardial ischemia. Such patients must have documented evidence of previous coronary artery disease (CAD) with at least one of the following:
- Prior MI requiring hospitalization
- Prior revascularization procedure (more than 3 months ago)
- Cardiac catheterization showing significant CAD
- Positive exercise test
- Other objective evidence of atherosclerotic vascular disease or
- Already elevated cardiac enzymes or troponin I or T above the upper limit of normal.
1.2 STEMI patients
- Presenting with signs or symptoms of acute myocardial infarction lasting at least 20 minutes and planned to be managed with an invasive strategy with intent to perform a percutaneous coronary intervention (PCI) during the index hospitalization.
Definite ECG changes compatible with STEMI: persistent ST-elevation (> 2 mm in two contiguous precordial leads or > 1 mm in at least two limb leads), or new left bundle branch block, or Q-wave in 2 contiguous leads
2) Randomized during index hospitalization for acute coronary syndrome 3) Suitable candidate for either radial or femoral artery PCI 4) Intent to perform same-sitting angiography and PCI. 5) Palpable radial artery with documented normal Allen's test 6) Acceptance by operator to use whichever route is assigned by the randomization process 7) Previous experience of the operator with at least 50 cases of radial artery access within the past year 8) Written informed consent
EXCLUSION CRITERIA
- Age < 18 years
- Active bleeding or significant increased risk of bleeding, severe hepatic insufficiency, current peptic ulceration, proliferative diabetic retinopathy.
- Uncontrolled hypertension
- Cardiogenic shock
- Prior CABG surgery with use of more than one internal mammary artery
- Documented severe peripheral vascular disease precluding a femoral approach
- Participation in any study with an investigational drug or device within the previous 30 days
- Medical, geographic or social factors making study participation impractical
Contacts and Locations| Canada, Ontario | |
| Hamilton Health Sciences | |
| Hamilton, Ontario, Canada, L8L 2X2 | |
| Principal Investigator: | Sanjit Jolly, MD, MSc, FRCPC | Population Health Research Institute |
| Study Director: | Susan Chrolavicius | Population Health Research Institute |
| Principal Investigator: | Shamir Mehta, MD, MSc, FRCP(C), FACC | Population Health Research Institute |
More Information
Additional Information:
No publications provided by Population Health Research Institute
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Sanjit Jolly, MD, MSc, FRCPC, Population Health Research Institute |
| ClinicalTrials.gov Identifier: | NCT01014273 History of Changes |
| Other Study ID Numbers: | Rad-Fem PCI Access Study |
| Study First Received: | November 13, 2009 |
| Last Updated: | April 6, 2011 |
| Health Authority: | Canada: Ethics Review Committee United States: Institutional Review Board Czech Republic: Ethics Committee Finland: Ethics Committee Hungary: National Institute of Pharmacy Slovenia: Ethics Committee Australia: Human Research Ethics Committee France: Institutional Ethical Committee India: Institutional Review Board Italy: Ethics Committee New Zealand: Institutional Review Board Poland: Ethics Committee Spain: Ethics Committee Bulgaria: Ministry of Health Brazil: Ethics Committee Chile: Instituto de Salud Publica de Chile Israel: Ministry of Health Malaysia: Ministry of Health |
Keywords provided by Population Health Research Institute:
|
Acute Coronary Syndrome PCI Percutaneous Coronary Intervention Radial Access |
Additional relevant MeSH terms:
|
Angina, Unstable Infarction Myocardial Infarction Acute Coronary Syndrome Angina Pectoris Myocardial Ischemia Heart Diseases Cardiovascular Diseases |
Vascular Diseases Chest Pain Pain Signs and Symptoms Ischemia Pathologic Processes Necrosis |
ClinicalTrials.gov processed this record on May 23, 2013